BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Garrett Motion
GTX
$5.35B
| $135K | ﹤0.01% |
13,536
-324
| -2% | -$3.3K |
|
3027
IAMGOLD
IAG
$10.1B
| $135K | ﹤0.01% |
36,208
-1,389
| -4% | -$4.91K |
|
3028
Dime Commercial Bancshares
DCOM
$1.82B
| $135K | ﹤0.01% |
4,022
+1,359
| +51% | +$43.6K |
|
3029
Hanmi Financial
HAFC
$963M
| $134K | ﹤0.01% |
6,722
+1,892
| +39% | +$36.5K |
|
|
ACH
3030
Accendra Health
ACH
$84.6M
| $134K | ﹤0.01% |
25,975
+12,183
| +88% | +$78.2K |
|
3031
Haverty Furniture Companies
HVT
$450M
| $134K | ﹤0.01% |
6,635
+3,688
| +125% | +$74.5K |
|
|
SMC
3032
Summit Midstream
SMC
$480M
| $134K | ﹤0.01% |
2,692
+1,152
| +75% | +$69.1K |
|
3033
NRC Health Common Stock
NRC
$471M
| $134K | ﹤0.01% |
2,027
-43
| -2% | -$2.63K |
|
|
NXRT
3034
NexPoint Residential Trust
NXRT
$636M
| $133K | ﹤0.01% |
2,960
-42
| -1% | -$1.98K |
|
3035
Karyopharm Therapeutics
KPTI
$45.1M
| $133K | ﹤0.01% |
463
-81
| -15% | -$17.6K |
|
|
DO
3036
DELISTED
Diamond Offshore Drilling
DO
| $133K | ﹤0.01% |
18,460
+4,278
| +30% | +$24.9K |
|
3037
Agilysys
AGYS
$3.25B
| $133K | ﹤0.01% |
5,220
+2,285
| +78% | +$57.8K |
|
3038
Tootsie Roll Industries
TR
$3.02B
| $132K | ﹤0.01% |
4,768
+832
| +21% | +$23.5K |
|
3039
LeMaitre Vascular
LMAT
$1.87B
| $132K | ﹤0.01% |
3,666
+1,116
| +44% | +$38.5K |
|
3040
Ezcorp Inc
EZPW
$1.76B
| $132K | ﹤0.01% |
19,318
+10,697
| +124% | +$61.4K |
|
3041
Coherus Oncology
CHRS
$176M
| $131K | ﹤0.01% |
7,295
-2,309
| -24% | -$42.6K |
|
3042
Carter Bankshares
CARE
$757M
| $131K | ﹤0.01% |
5,502
+2,641
| +92% | +$54.6K |
|
3043
HCI Group
HCI
$2.32B
| $130K | ﹤0.01% |
2,855
+1,486
| +109% | +$65.5K |
|
3044
Expro Ltd
XPRO
$2.1B
| $130K | ﹤0.01% |
4,196
+1,339
| +47% | +$41K |
|
3045
UNIFI
UFI
$120M
| $129K | ﹤0.01% |
5,125
+2,691
| +111% | +$65K |
|
3046
B2Gold
BTG
$6.7B
| $129K | ﹤0.01% |
+32,257
| New | +$114K |
|
|
JCP
3047
DELISTED
J.C. Penney Company, Inc.
JCP
| $129K | ﹤0.01% |
115,104
+59,652
| +108% | +$63.4K |
|
|
CPLG
3048
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $129K | ﹤0.01% |
12,053
+4,658
| +63% | +$47K |
|
|
ATRI
3049
DELISTED
Atrion Corp
ATRI
| $129K | ﹤0.01% |
171
-60
| -26% | -$45.3K |
|
|
CCF
3050
DELISTED
Chase Corporation
CCF
| $128K | ﹤0.01% |
1,084
-87
| -7% | -$10.1K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.